ExPrimary, founded in 2013 and headquartered in Rockville, Maryland, is a biotechnology company focused on developing innovative medical devices for cell analysis. The company's core mission is to enhance access to bioanalytical tools within research and diagnostic markets, particularly to support the growing needs of personalized healthcare. ExPrimary's products are designed to count and store cells efficiently, leveraging advanced technologies to provide high-performance instrumentation at a lower cost compared to existing solutions.
Notable figures affiliated with ExPrimary include experienced professionals from the biotech industry who drive the company's innovative efforts. The company has garnered attention for its state-of-the-art assay content and cost-effective bioanalysis instruments. ExPrimary's impact lies in its ability to democratize access to essential bioanalytical tools, thereby supporting advancements in both research and personalized medicine.
